Vicky is a life sciences lawyer who specialises in commercial intellectual property matters. She has over twenty years of experience drafting, negotiating and advising on agreements associated with the development, transfer and exploitation of technology, materials and data in the life sciences sector. Vicky’s expertise includes advising on collaboration agreements, research and development agreements, services agreements, assignment agreements, manufacturing agreements and patent and know-how licensing agreements.
Drawing upon her scientific background, Vicky works with her clients’ scientific and commercial teams, assisting with the development, protection and exploitation of their biotechnology inventions, materials and know-how. Vicky is familiar with the complex legal and commercial issues that arise in relation to cutting edge life sciences innovation such as antibodies, cell lines, cell therapies, gene therapies, gene sequencing and gene edited organisms, including in the context of their use as research tools, diagnostics and medicines. Her clients include individuals, research organisations and private and listed companies.
Expertise
Vicky advises innovators (including scientists, research organisations and pharmaceutical and biotech companies) on agreements relating to their technology – including research and development agreements, collaboration agreements, services agreements (for example with contract research organisations), manufacturing agreements (for chemicals and biologicals) and patent and know-how licensing agreements.
Experience
- Advising a gene therapy delivery company on its research collaboration with a US public benefit corporation
- Developing a suite of standard form agreements for a major pharmaceutical manufacturer, including agreements relating to the manufacture of biologicals and biosimilars
- Acting for an innovator antibody company in relation to its research and development collaborations with third party companies and academic institutions
- Acting for a variety of companies in relation to agreements relating to biobanks – including in relation to depositing and accessing biological samples and exploiting the results of access
Vicky specialises in advising on the drafting and negotiation of commercial agreements relating predominantly to patents, know-how/trade secrets and biological materials, including licences, assignments, collaboration and technology evaluation agreements.
Experience
- Advising a biotechnology company on the exclusive worldwide licensing of its patented, platform, drug delivery technology to a major pharmaceutical company
- Advising a synthetic plant biology company on its collaboration and licensing agreements relating to its patented gene editing technology
- Representing the proprietor of an established hormone-based therapy on the negotiation and completion of a worldwide exclusive commercialisation licence, including rights to product licences, know-how and trademarks
- Creating and keeping updated a suite of template commercial agreements for an epigenetic diagnostic company, including its confidentiality agreement, material transfer agreement, master collaboration agreement and standard terms and conditions for high throughput sales of RUO and diagnostic kits
Vicky is a life sciences lawyer who advises on agreements relating to the research, development and exploitation of innovation within the biotechnology sector, including material transfer agreements, technology evaluation agreements, collaboration agreements, services agreements, research and development agreements, manufacturing agreements and patent and know-how licensing agreements.
Experience
- Advising a cancer diagnostics business on its commercial agreements relating to the research, development and licensing of its proprietary assays
- Advising an innovative diagnostics company on a suite of significant agreements relating to the research, development and exploitation of its epigenetic biomarker technology
- Advising a biotechnology company on a worldwide licensing agreement with a major pharmaceutical company in relation to its proprietary antibody for the treatment and diagnosis of disease
- Advised an innovative, virtual biotechnology company developing small molecule inhibitors for the treatment of disease on its outsourcing agreements with CROs and manufacturers
- Advising a biotechnology company on its collaborations with universities and other academic institutions throughout the world, including advice on accessing valuable biological samples and clinical data
- Advising an innovative company on cell line licences required for the development of its proprietary biological medicines
- Advising a research organisation on its collaborations with universities and commercial partners, including use of standard form Lambert agreements to achieve speedy agreements
- Advising an alternative alcohol development company on agreements required to access medicinal chemistry services and exploit compound libraries
Please note: The experience list above may include examples of work completed prior to joining Keystone Law.
Recognition
Recognised in Chambers UK for Life Sciences: Transactional 2022 – 2027
Acknowledged by Chambers 2025 for advising on research, licensing and collaboration agreements. Her clients include an array of emerging companies working at the forefront of innovation in the sector.
Recognised by The Legal 500 for Life Sciences and Healthcare 2025
Recognised by Best Lawyers (UK) for Life Sciences 2023-2025
“We are really pleased with her representation, and we continue to work with her.”
Chambers UK 2027
“Vicky is a brilliant solicitor”
Chambers UK 2025
“Vicky is an exceptional commercial IP lawyer and can hold her own in the biggest of negotiations”
Chambers UK 2025
“Vicky Clark is a highly experienced IP solicitor who provided us with clear, robust advice in complex global IP licensing contract negotiations”
Chambers UK 2025
“Vicky Clark is very experienced, responsive and detailed where necessary”
Chambers UK 2024
“Vicky Clark is a highly experienced commercial IP lawyer with great depth of knowledge in the pharmaceutical and biotech sectors”
Chambers UK 2023
“Vicky Clark takes the time to explain issues thoroughly from a legal and business perspective, making the impact of contract clauses accessible to the non-expert”
Chambers UK 2022
“Vicky Clark is phenomenal”
Chambers UK 2021
“Vicky is extremely knowledgeable and commercial. She has a relaxed but firm style which helps in tough discussions”
Chambers UK 2019
“She's very bright and very commercial”
Chambers UK 2018
“Highly experienced lawyer with a scientific background who is a pleasure to work with”
Chambers UK 2017
“Knowledgeable and quick”
Legal 500 2016
“Intelligence, business acumen and congenial personality”
Chambers UK 2016
“Excellent service – she was very responsive to our needs and rapidly turned around work to tight deadlines”
Chambers UK 2015
“Provides strong advice and known for her wonderful bedside manner”
Chambers UK 2014
Vicky qualified as a solicitor in 1997. Prior to joining Keystone Law in 2010, she worked at the following firms:
- Bristows
- Ashurst Morris Crisp
Vicky's latest news and resources
Can an intellectual property licence last forever?
Vicky Clark & Maureen Kelly
Keystone Law advises Gedeon Richter on its acquisition of Celmatix Inc’s research portfolio
Maureen Kelly, Vicky Clark & Catherine Williams
Contract liability caps: what can we learn from the Portsmouth University case?
Vicky Clark